PROVENTIL

LOE Approaching

albuterol

NDAINHALATIONAEROSOL, METEREDPriority Review
Approved
May 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT06664619Phase 3Recruiting

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Started Dec 2024
724 enrolled
Asthma
NCT06563102Phase 4Completed

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

Started Sep 2024
101 enrolled
Mild Asthma
NCT06514157Phase 1Completed

Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.

Started Aug 2024
14 enrolled
Healthy Volunteer
NCT06290102Phase 1Completed

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

Started May 2024
30 enrolled
Asthma
NCT06245551Phase 3Completed

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma

Started Dec 2023
64 enrolled
Asthma, Exercise-Induced